InspireMD, Inc. financials

NSPR CIK 0001433607

Source: EDGAR filings · Built 2026-06-02T03:41:12Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -36.77M -23.27M -16.76M -16.02M -13.55M -9.17M
EBITDA 426.39M 246.50M 210.86M 169.29M -14.55M -10.23M
Working Capital 50.76M 32.84M 38.14M 16.26M 32.75M 11.63M
Net Debt -5.65M -16.58M -7.30M -3.02M -10.80M -11.65M
Gross Margin 29.50% 21.49% 29.12% 21.60% 16.77% 3.34%
Operating Margin -552.56% -478.00% -340.74% -361.88% -327.39% -417.71%
Net Margin -543.33% -456.63% -320.97% -357.59% -331.88% -424.31%
Return on Equity (ROE) -88.38% -88.69% -50.42% -106.31% -44.49% -86.69%
Return on Assets (ROA) -70.29% -68.38% -41.80% -75.01% -37.57% -59.31%
Current Ratio 5.74× 5.28× 7.34× 4.21× 8.53× 4.14×
Debt-to-Equity 0.06× 0.06× 0.06× 0.09× 0.04× 0.08×
Effective Tax Rate -0.13% -0.18% -0.33% -0.15% -0.30% -0.04%
Cash Conversion Ratio 0.72× 0.68× 0.82× 0.84× 0.89× 0.86×
Accruals Ratio -0.20× -0.22× -0.07× -0.12× -0.04× -0.08×
SBC % of Revenue 137.34% 144.64% 72.36% 45.48% 35.06% 24.39%
CapEx Coverage -21.12× -15.60× -42.98× -32.86× -38.40× -103.19×
Free Cash Flow Per Share $-0.57 $-0.56 $-0.69 $-2.03 $-1.85 $-6.06

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
EV / EBITDA 0.17× 0.22× 0.26× 0.02×
P/S 8.63× 9.99× 9.89× 1.39× 5.57× 0.45×
P/B 1.40× 1.94× 1.55× 0.41× 0.75× 0.09×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 8.98M 7.01M 6.21M 5.17M 4.50M 2.48M
Cost of Goods and Services Sold 6.33M 5.50M 4.40M 4.05M 3.74M 2.40M
Gross Profit 2.65M 1.51M 1.81M 1.12M 754.00K 83.00K
Research and Development Expense 15.00M 13.63M 7.98M 7.81M 5.16M 2.23M
Operating Expenses 52.26M 35.01M 22.95M 19.83M 15.47M 10.46M
Operating Income (Loss) -49.61M -33.50M -21.14M -18.71M -14.72M -10.38M
Income Tax Expense (Benefit) 63.00K 59.00K 65.00K 28.00K 45.00K 4.00K
Net Income (Loss) Attributable to Parent -48.79M -32.01M -19.92M -18.49M -14.92M -10.54M
Earnings Per Share, Basic $-0.76 $-0.76 $-0.82 $-2.35 $-2.03
Weighted Average Number of Shares Outstanding, Basic 64.33M 41.93M 24.27M 7.87M 7.35M
Earnings Per Share, Diluted $-0.76 $-0.76 $-0.82 $-2.35
Weighted Average Number of Shares Outstanding, Diluted 64.33M 41.93M 24.27M 7.87M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 8.94M 18.92M 9.64M 4.63M 12.00M 12.64M
Assets, Current 61.47M 40.52M 44.16M 21.33M 37.09M 15.34M
Assets 69.40M 46.81M 47.64M 24.65M 39.71M 17.78M
Liabilities, Current 10.71M 7.68M 6.02M 5.07M 4.35M 3.71M
Liabilities 14.20M 10.72M 8.14M 7.26M 6.18M 5.61M
Stockholders' Equity Attributable to Parent 55.20M 36.09M 39.50M 17.39M 33.53M 12.16M
Common Stock, Shares, Outstanding 43.53M 26.61M 21.84M 8.33M 8.30M 3.28M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -35.10M -21.87M -16.38M -15.54M -13.21M -9.08M
Payments to Acquire Property, Plant, and Equipment 1.66M 1.40M 381.00K 473.00K 344.00K 88.00K
Net Cash Provided by (Used in) Investing Activities -30.56M 12.64M -16.09M 8.44M -22.46M -187.00K
Net Cash Provided by (Used in) Financing Activities 55.57M 18.45M 37.53M -140.00K 35.03M 16.39M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (NSPR CIK 0001433607), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

LSF

Laird Superfood, Inc.

TECX

TECTONIC THERAPEUTIC, INC.

CNA

CNA FINANCIAL CORP